Search
Stoke Therapeutics Inc
STOKAdd to Watchlist
32.710USD
-0.010-0.03%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.04BMarket Cap
LossP/E TTM
Stoke Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
184.42M
404.50%
EPS(YoY)
-0.12
92.94%
Analyst Rating
STRONG BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its total revenue reached 184.42M, with a year-on-year change of 404.50.
What are the current assets of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its current assets were 305.70M, with a year-on-year change of 31.34.
What are the total assets of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its total assets of Stoke Therapeutics Inc were 418.43M, with a year-on-year change of 54.09.
What are the total liabilities of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its total liabilities of Stoke Therapeutics Inc were 65.98M, with a year-on-year change of 55.12.
What is the total equity of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its total equity of Stoke Therapeutics Inc was 352.46M, with a year-on-year change of 53.90.
What is the net investment of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its net investment of Stoke Therapeutics Inc was -186.81M, with a year-on-year change of -73.82.
What is the net financing of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its net financing of Stoke Therapeutics Inc was 97.39M, with a year-on-year change of -25.71.
What is the Earnings Per Share (EPS) of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.12, with a year-on-year change of 92.94.
What is the net margin of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its net profit margin was -3.73, with a year-on-year change of 98.47.
What is the Return on Equity (ROE) of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -2.37, with a year-on-year change of 94.83.
What is the Return on Assets (ROA) of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -2.00, with a year-on-year change of 94.39.
What is the operating profit of Stoke Therapeutics Inc?
According to Stoke Therapeutics Inc's FY2025 earnings report, its operating profit was -20.59M, with a year-on-year change of 79.69.